NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027
Putting Patients First Blog
JULY 2, 2024
Without appropriate guardrails, CMS’ broad definition of drugs eligible for negotiation may discourage these types of improvements. Prior authorization and association with delayed or discontinued prescription fills. Active Moiety and Single Source Qualifying Drugs (Section 30.1) and Keating, N. link] xii Chino, F., and Thom, B.
Let's personalize your content